The first segment of the tape is introduced by an overview of the costs and consequences of drug use in the workplace, namely, inferior and reduced productivity, absenteeism, and increased safety risks on the job. Three panel members then focus on the rationale for and the implementation of the Federal Drug Free Workplace Act, which applies to all prime grantees and contractors of the Federal Government. One panel member, a representative of the Office of Management and Budget, details the act's requirements, i.e., an employer written drug policy distributed to each employee, a drug free awareness program (education), employer notification to the Federal Government of any known employee drug conviction related to the workplace, sanctions for employees abusing illegal drugs, and good faith compliance with the act. Two other panel members discuss the rationale for the act and the use of an Employee Assistance Program to help employees address their drug problems. The second segment of the panel discussion focuses on employee drug testing and the legal parameters governing it. Issues include Federal and State laws governing testing, the importance of testing accuracy, and employee privacy in giving the sample. One panel member discusses how to identify an effective drug treatment program.